These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29043174)

  • 1. Development of a safer laboratory vervet monkey model for the study of human African trypanosomiasis.
    Waema M; Maina N; Karanja S; Gachie B; Ngotho M; Kagira J
    Afr J Lab Med; 2014; 3(1):100. PubMed ID: 29043174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of trypanocidal therapy on the haematology of vervet monkeys experimentally infected with Trypanosoma brucei rhodesiense.
    Ngotho M; Kagira JM; Kariuki C; Maina N; Thuita JK; Mwangangi DM; Farah IO; Hau J
    Acta Trop; 2011 Jul; 119(1):14-8. PubMed ID: 21420376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM, lgG and IL-6 profiles in the Trypanosoma brucei brucei monkey model of human African trypanosomiasis.
    Waema MW; Maina NW; Ngotho M; Karanja SM; Gachie BM; Maranga DN; Kagira JM
    Acta Trop; 2017 Apr; 168():45-49. PubMed ID: 28099874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma brucei rhodesiense transmitted by a single tsetse fly bite in vervet monkeys as a model of human African trypanosomiasis.
    Thuita JK; Kagira JM; Mwangangi D; Matovu E; Turner CM; Masiga D
    PLoS Negl Trop Dis; 2008; 2(5):e238. PubMed ID: 18846231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vervet monkey (Chlorocebus aethiops) as an experimental model for Trypanosoma brucei gambiense human African trypanosomiasis: a clinical, biological and pathological study.
    Ouwe-Missi-Oukem-Boyer O; Mezui-Me-Ndong J; Boda C; Lamine I; Labrousse F; Bisser S; Bouteille B
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):427-36. PubMed ID: 16325877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunospecific immunoglobulins and IL-10 as markers for Trypanosoma brucei rhodesiense late stage disease in experimentally infected vervet monkeys.
    Ngotho M; Kagira JM; Jensen HE; Karanja SM; Farah IO; Hau J
    Trop Med Int Health; 2009 Jul; 14(7):736-47. PubMed ID: 19573160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-6 is upregulated in late-stage disease in monkeys experimentally infected with Trypanosoma brucei rhodesiense.
    Nyawira Maranga D; Kagira JM; Kinyanjui CK; Muturi Karanja S; Wangari Maina N; Ngotho M
    Clin Dev Immunol; 2013; 2013():320509. PubMed ID: 24194772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma brucei gambiense infection in vervet monkeys: a potential model for early-stage disease.
    Gachie BM; Kagira JM; Karanja SM; Waema MW; Ngotho JM; Maina NW
    J Med Primatol; 2014 Apr; 43(2):72-7. PubMed ID: 24494926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosoma brucei rhodesiense: use of an antigen detection enzyme immunoassay for evaluation of response to chemotherapy in infected vervet monkeys (Cercopithecus aethiops).
    Gichuki CW; Nantulya VM; Sayer PD
    Trop Med Parasitol; 1994 Sep; 45(3):237-42. PubMed ID: 7899795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-10 is up regulated in early and transitional stages in vervet monkeys experimentally infected with Trypanosoma brucei rhodesiense.
    Ngotho M; Maina N; Kagira J; Royo F; Farah IO; Hau J
    Parasitol Int; 2006 Dec; 55(4):243-8. PubMed ID: 16901747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loop Mediated Isothermal Amplification for Detection of Trypanosoma brucei gambiense in Urine and Saliva Samples in Nonhuman Primate Model.
    Ngotho M; Kagira JM; Gachie BM; Karanja SM; Waema MW; Maranga DN; Maina NW
    Biomed Res Int; 2015; 2015():867846. PubMed ID: 26504841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the impact of targeting livestock for the prevention of human and animal trypanosomiasis, at village level, in districts newly affected with T. b. rhodesiense in Uganda.
    Hamill L; Picozzi K; Fyfe J; von Wissmann B; Wastling S; Wardrop N; Selby R; Acup CA; Bardosh KL; Muhanguzi D; Kabasa JD; Waiswa C; Welburn SC
    Infect Dis Poverty; 2017 Feb; 6(1):16. PubMed ID: 28162093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of mass chemotherapy in domestic livestock for control of zoonotic T. b. rhodesiense human African trypanosomiasis in Eastern Uganda.
    Fyfe J; Picozzi K; Waiswa C; Bardosh KL; Welburn SC
    Acta Trop; 2017 Jan; 165():216-229. PubMed ID: 27570206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteome characterization in various biological fluids of Trypanosoma brucei gambiense-infected subjects.
    Bonnet J; Garcia C; Leger T; Couquet MP; Vignoles P; Vatunga G; Ndung'u J; Boudot C; Bisser S; Courtioux B
    J Proteomics; 2019 Mar; 196():150-161. PubMed ID: 30414516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kenyan purple tea anthocyanins and coenzyme-Q10 ameliorate post treatment reactive encephalopathy associated with cerebral human African trypanosomiasis in murine model.
    Rashid K; Wachira FN; Nyariki JN; Isaac AO
    Parasitol Int; 2014 Apr; 63(2):417-26. PubMed ID: 24440762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genital lesions in male red fronted gazelles (Gazella rufifrons) experimentally infected with Trypanosoma brucei and the effect of melarsamine hydrochloride (Cymelarsan®) and diminazene aceturate (Berenil®) in its treatment.
    Mbaya AW; Nwosu CO; Kumshe HA
    Theriogenology; 2011 Sep; 76(4):721-8. PubMed ID: 21601916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma brucei rhodesiense infection in vervet monkeys. I. Parasitologic, hematologic, immunologic and histologic results.
    Schmidt H; Sayer P
    Tropenmed Parasitol; 1982 Dec; 33(4):249-54. PubMed ID: 7164166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid metabolism and other metabolic changes in vervet monkeys experimentally infected with Trypanosoma brucei rhodesiense.
    Gaithuma AK; Karanja SM; Ngotho M; Maathai RG; Kagira JM; Maina NW
    J Med Primatol; 2012 Apr; 41(2):75-81. PubMed ID: 22070162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of blood cerebrospinal fluid barrier permeability impairment in Trypanosoma rhodesiense infection in vervet monkeys.
    Waitumbi JN; Sayer PD; Gould SS
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):502-5. PubMed ID: 3197248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginkgo biloba attenuated detrimental inflammatory and oxidative events due to Trypanosoma brucei rhodesiense in mice treated with melarsoprol.
    Wendo JK; Mbaria JM; Nyariki JN; Isaac AO
    PLoS Negl Trop Dis; 2024 Apr; 18(4):e0012103. PubMed ID: 38620045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.